Pediatric Psychopharmacology by Andres MartinPediatric Psychopharmacology by Andres Martin

Pediatric Psychopharmacology

EditorAndres Martin, Lawrence D. Scahill, Christopher J. Kratochvil

Hardcover | December 7, 2010

Pricing and Purchase Info


Earn 1,293 plum® points

Prices and offers may vary in store


Ships within 1-2 weeks

Ships free on orders over $25

Not available in stores


When the first edition of Pediatric Psychopharmacology published in 2002, it filled a void in child and adolescent psychiatry and quickly established itself as the definitive text-reference in pediatric psychopharmacology. While numerous short, clinically focused paperbacks have beenpublished since then, no competitors with the scholarly breadth, depth, and luster of this volume have emerged. In the second edition, Christopher Kratochvil, MD, a highly respected expert in pediatric psychopharmacology, joins the outstanding editorial team led by Dr. Martin and Dr. Scahill. In thenew edition, the editors streamline the flow of information to reflect the growth in scientific data since the first edition appeared. The overall structure of the book remains the same, with major sections on underlying biology; somatic interventions; assessment and treatment; and specialconsiderations.
Andres Martin, MD, MPH is the Riva Ariella Ritvo Professor at the Yale Child Study Center. He serves as medical director of the Children's Psychiatric Inpatient Service (CIPS) at Yale-New Haven Children's Hospital, and as editor-in-chief of the flagship Journal of the American Academy of Child and Adolescent Psychiatry. Lawrence Scahil...
Title:Pediatric PsychopharmacologyFormat:HardcoverDimensions:784 pages, 11 × 8.5 × 0.98 inPublished:December 7, 2010Publisher:Oxford University PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0195398211

ISBN - 13:9780195398212

Look for similar items by category:


Table of Contents

Section I - Biological Basses of Pediatric PsychopharmacologyI-A Developmental Principles of Neurobiology and Pscyhopharmacology1. Flora M. Vaccarino and James F. Leckman: Overview of Brain Development2. Stephan Heckers, Christine Konradi and George M. Anderson: Synaptic Function, Biochemical Neuroanatomy, and Psychotropic Drug Action3. Alexander A. Vinks and Philip D. Walson: Developmental Principles of Pharmacokinetics4. Jessica Oesterheld and Miia Turpeinen: Cytochrome P450-Mediated InteractionsI-B Genetic Principles5. Susan Goebel-Goody, Surojit Paul and Paul Lombroso: Molecular Genetics6. George M. Anderson, Jeremy Veenstra-VanderWeele, Edwin H. Cook and James T. McCraken: PharmacogeneticsI-C Developmental Psychopathology7. A.F.T. Arnsten and F.X. Castellanos: Neurobiology of Attention Regulation and its Disorders8. Joan Kaufman and Natalie Weder: **Neurobiology of Early-Life Stress and its Disorders9. Frank P. MacMaster, David R. Rosenberg and Joan Kaufman: Neurobiology of Early-Onset Mood Disorders10. Kate B. Nooner, Amy K. Roy and Daniel S. Pine: Neurobiology of Early-Onset Anxiety Disorders11. Tanya K. Murphy, Kytja K.S. Voeller and S. Evelyn Stewart: Neurobiology of Obsessive-Compulsive Disorder12. James F. Leckman, Michael H. Bloch, Michelle Hampson and Robert A. King: Neurobiology of Tic Disorders, Including Tourette's13. Anand Mattai, Judith L. Rapoport and Nitin Gogtay: Neurobiology of Childhood Schizophrenia and Related Disorders14. Alexander Westphal and Kevin Pelphrey: **Neurobiology of Autism-Spectrum Disorders15. Markus J. P. Kruesi, Sondra Keller and Julie Ann Jensen: Neurobiology of Aggression16. Johannes Hebebrand, Kerstin Konrad and Beate Herpetz-Dahlmann: **Neurobiology of Eating Disorders17. Kathryn J. Reissner and Peter W. Kalivas: **Neurobiology of Substance Abuse DisordersSection II: Somatic InterventionsII-A Psychotropic Agents18. J. Daughton and Christopher Kratochvil: **Stimulants19. Jeffrey H. Newcorn, Suzanne Clerkin, Kurt P. Schulz and Jeffrey M. Halperin: **Non-Stimulant Alternatives: Adrenergic Agonists and Atomoxetine20. Paul E. Croarkin, Graham J. Emslie and Taryn L. Mayes: **Antidepressants I: Selective Serotonin Reuptake Inhibitors21. Emily Frosch: **Antidepressants II: Other Agents22. Robert A. Kowatch, Jeffrey R. Strawn and Arman Danielyan: **Mood Stabilizers: Lithium, Anticonvulsants and Others23. Cristoph U. Correll: **Antipsychotic Agents: Traditional and Atypical24. Shannon R. Barnett and Mark A. Riddle: Anxiolytics: Benzodiazepines, Buspirone, and OthersII-B Other Somatic Interventions25. Joseph M. Rey, Garry Walter and Nerissa Soh: Complementary and Alternative Medicine in Pediatric Psychopharmacology26. Garry Walter, Joseph M. Rey, Neera Ghaziuddin and Colleen Loo: Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS)Section III: Assessment and TreatmentIII-A General Principles27. Carlo G. Carandang, Christopher J. Kratochvil, Lawrence Scahill and Andres Martin: **Running a Pediatric Psychopharmacology Clinic: Practical Aspects28. Elizabeth Hurt, L. Eugene Arnold and Michael G. Aman: Clinical Instruments and Scales in Pediatric Psychopharmacology29. Christopher J. Kratochvil, Karen Wells and John S. March: Combining Pharmacotherapy and Psychotherapy: An Evidence-Based Approach30. Kyle D. Pruett, Shashank V. Joshi and Andres Martin: Thinking About Prescribing: The Psychology of PsychopharmacologyIII-B Specific Disorders and Syndromes31. Thomas Spencer, Joseph Biederman and Timothy Wilens: Assessment and Treatment of Attention Deficit Hyperactivity Disorder32. Boris Birmaher and David Brent: Assessment and Treatment of Child and Adolescent Depression33. Jayasree J. Nandagopal and Melissa P. DelBello: **Assessment and Treatment of Child and Adolescent Bipolar Disorder34. Jayasree J. Nandagopal and Melissa P. DelBello: **Assessment and Treatment of Anxiety Disorders35. Gagan Joshi and Daniel A. Geller: Assessment and Treatment of Obsessive Compulsive Disorder36. Lawrence Scahill, Robert A. King, Paul Lombroso, Denis G. Sukhodolsky and James F. Leckman: **Assessment and Treatment of Tourette's Syndrome and Other Tic Disorders37. Linmarie Sikich and Terrence Carter Bethea: **Assessment and Treatment of Early-Onset Schizophrenia38. Christopher J. McDougle and David J. Posey: Assessment and Treatment of Autistic and Other Pervasive Developmental Disorders39. Craig L. Donnelly and Jennifer L. McLaren: Assessment and Treatment of Post Traumatic Stress Disorder40. Beate Herpertz-Dahlmann and Johannes Hebebrand: **Assessment and Treatment of Eating DisordersIII-C Special Clinical Populations41. Martin Gignac, James G. Waxmonsky and Timothy Wilens: Considerations in the Treatment of Substance Abusing Youths42. Michael G. Aman, Cristan A. Farmer, Ronald L. Lindsay and L. Eugene Arnold: Considerations in the Treatment of Individuals with Mental Retardation43. Jonathan A. Slater, John Saroyan and Nika Dyakina: Psychopharmacology in the Medically Ill Child or Adolescent44. C. Neill Epperson: Psychopharmacology During Pregnancy: Infant Considerations45. Mary Margaret Gleason: **Psychopharmacological Treatment of Preschoolers46. Judith A. Owens: **Sleep-related Disorders, Including InsomniaIII-D Other Areas of Clinical Concern47. Bruce Meltzer, Martha Castro and Jean A. Frazier: Pharmacological Management of Agitation and Aggression48. William Reiner: Management of Elimination and Other Pelvic Disorders: Enuresis, Encopresis, and Psychopharmacological Effects on Sexual FunctionSection IV: Edidemiological, Research, and Methodological Considerations49. Peter S. Jensen: Pediatric Psychopharmacoepidemiology: Who Is Prescribing? And For Whom, How, and Why?50. Benedetto Vitiello and Lawrence Scahill: **Aspects of Clinical Trials Methodology and Design Relevant to Child and Adolescent Psychopharmacology51. Thomas P. Laughren and Mark A. Ritter: Regulatory Issues in Pediatric Psychopharmacology52. Mary Lynn Dell, Brigitte S. Vaughan and Christopher Kratochvil: Ethical Issues in Pediatric Psychopharmacology Research53. Garry Walter, Joseph M. Rey, Christopher R. Thomas and Andres Martin: **Conflicts of Interest and Pediatric Psychopharmacology54. Daniel Safer and Julie Zito: **International Perspectives on Pediatric Psychopharmacology